"The iMM – Instituto de Medicina Molecular João Lobo Antunes is a leading Portuguese private non-profit research institute that offers a vibrant scientific environment, aiming to nurture innovative ideas in basic, clinical and translational biomedical research. Created in 2002, iMM has established itself as a leading national and internationally competitive biomedical institute. Its strategy has been defined by promotion of excellence, leveraged by high-quality human resources, increasing expenditure in infrastructures and knowledge transfer to the society. iMM is an inclusive, equal opportunity employer offering attractive conditions and benefits."

During the past decade, Instituto de Medicina Molecular conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Instituto de Medicina Molecular" #1 collaborator was "Instituto de Medicina Molecular João Lobo Antunes" with 1 trials as a collaborator, "Ludwig-Maximilians - University of Munich" with 1 trials as a collaborator, "Lund University" with 1 trials as a collaborator, "Merck Sharp & Dohme LLC" with 1 trials as a collaborator and "Philipps University Marburg Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Instituto de Medicina Molecular" are "Ankylosing Spondylitis" (1 trials), "Bone Resorption" (1 trials), "Late Stage Parkinson's Disease" (1 trials), "Parkinson's Disease" (1 trials) and "Rheumatoid Arthritis" (1 trials). Many other conditions were trialed in "Instituto de Medicina Molecular" in a lesser frequency.

Most popular intervention types in "Instituto de Medicina Molecular" are "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Specialist review" (1 trials). Other intervention names were less common.

The vast majority of trials in "Instituto de Medicina Molecular" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Instituto de Medicina Molecular". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Instituto de Medicina Molecular, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Instituto de Medicina Molecular, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".